Enasidenib
Enasidenib (AG-221) is a small molecule inhibitor that selectively targets mutant IDH2 enzymes. It is used in research to study its effects in models of acute myeloid leukemia (AML), both in vitro and in vivo, for its potential to induce cellular differentiation.
Product Specifications
CAS Number
1446502-11-9
Product Name Alternative
AG-221
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
>98%
Bioactivity
Mutant isocitrate dehydrogenase 2 (IDH2) inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml)
Smiles
CC (C) (O) CNc1nc (Nc2ccnc (c2) C (F) (F) F) nc (n1) -c1cccc (n1) C (F) (F) F
Molecular Formula
C19H17F6N7O
Molecular Weight
473.38
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
2-Methyl-1-[[4-[6 (trifluoromethyl) -2-pyridinyl]-6-[[2- (trifluoromethyl) -4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]-2-propanol
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3137302 1.0 µg DNA
Gm15085 sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
MBS7146937 Inquire
Rabbit anti-Saccharomyces cerevisiae (strain 204508/S288c)(Baker's yeast) YPL108W Polyclonal Antibody
Sign In for Pricing
View Details MBS2132470-01 0.1 mL
HRP Linked Monoclonal Antibody to Cluster Of Differentiation 4 (CD4)
Sign In for Pricing
View Details MBS2132470-02 0.2 mL
HRP Linked Monoclonal Antibody to Cluster Of Differentiation 4 (CD4)
Sign In for Pricing
View Details MBS2132470-03 0.5 mL
HRP Linked Monoclonal Antibody to Cluster Of Differentiation 4 (CD4)
Sign In for Pricing
View Details